Guardant Health Inc
GH49.540USD
-0.960-1.90%
收盘 07/07, 16:00（美东）报价延迟15分钟
6.13B总市值
亏损市盈率 TTM
关于 Guardant Health Inc 公司
Guardant Health, Inc. 是一家精准肿瘤学公司，致力于守护健康并让每个人有更多时间远离癌症。该公司通过先进的血液和组织测试、真实世界数据和人工智能 (AI) 分析，提供有关疾病驱动因素的关键见解。Guardant 测试有助于改善所有护理阶段的结果，包括筛查以尽早发现癌症、监测早期癌症的复发以及帮助医生为晚期癌症患者选择最佳治疗方法。对于晚期癌症患者，该公司开发了 Guardant360 实验室开发测试 (LDT) 和 Guardant360 CDx，这是一种全面的液体活检测试，可为实体肿瘤提供肿瘤突变分析，并可用作非小细胞肺癌 (NSCLC) 和乳腺癌的伴随诊断。该公司还提供其他测试，包括 Guardant360 TissueNext 组织测试、Guardant Reveal 血液测试、Guardant360 Response 血液测试等。
公司简介
公司代码GH
公司名称Guardant Health Inc
上市日期Oct 04, 2018
成立日期2011
CEODr. Amirali Talasaz, Ph.D.
员工数量1999
证券类型Ordinary Share
年结日Oct 04
公司地址3100 Hanover Street
城市PALO ALTO
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编94304
电话18556988887
网址https://guardanthealth.com/
公司代码GH
上市日期Oct 04, 2018
成立日期2011
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Helmy A. Eltoukhy, Ph.D.
Dr. Helmy A. Eltoukhy, Ph.D.
Chairperson of the Board, Co-Chief Executive Officer
Chairperson of the Board, Co-Chief Executive Officer
2.75M
+0.43%
Dr. Amirali Talasaz, Ph.D.
Dr. Amirali Talasaz, Ph.D.
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
2.50M
-3.40%
Dr. Darya Chudova
Dr. Darya Chudova
Chief Technology Officer
Chief Technology Officer
80.44K
+1.88%
Mr. John Gomes Saia
Mr. John Gomes Saia
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
44.82K
+2.88%
Mr. Craig Eagle, M.D.
Mr. Craig Eagle, M.D.
Chief Medical Officer
Chief Medical Officer
36.79K
+4.75%
Ms. Vijaya V. Gadde
Ms. Vijaya V. Gadde
Independent Director
Independent Director
24.31K
+37.83%
Ms. Myrtle Stephens Potter
Ms. Myrtle Stephens Potter
Independent Director
Independent Director
18.15K
+29.09%
Mr. Kumud Kalia
Mr. Kumud Kalia
Chief Information Officer
Chief Information Officer
17.82K
+8.04%
Ms. Meghan V. Joyce
Ms. Meghan V. Joyce
Independent Director
Independent Director
11.15K
+42.11%
Mr. Musa Tariq
Mr. Musa Tariq
Independent Director
Independent Director
7.19K
+106.67%
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Helmy A. Eltoukhy, Ph.D.
Dr. Helmy A. Eltoukhy, Ph.D.
Chairperson of the Board, Co-Chief Executive Officer
Chairperson of the Board, Co-Chief Executive Officer
2.75M
+0.43%
Dr. Amirali Talasaz, Ph.D.
Dr. Amirali Talasaz, Ph.D.
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
2.50M
-3.40%
Dr. Darya Chudova
Dr. Darya Chudova
Chief Technology Officer
Chief Technology Officer
80.44K
+1.88%
Mr. John Gomes Saia
Mr. John Gomes Saia
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
44.82K
+2.88%
Mr. Craig Eagle, M.D.
Mr. Craig Eagle, M.D.
Chief Medical Officer
Chief Medical Officer
36.79K
+4.75%
Ms. Vijaya V. Gadde
Ms. Vijaya V. Gadde
Independent Director
Independent Director
24.31K
+37.83%
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Oncology
150.56M
74.00%
Biopharma and data
45.38M
22.30%
Screening
5.68M
2.79%
Licensing and other
1.86M
0.91%
地区USD
名称
营收
占比
United States
193.61M
95.15%
International
9.86M
4.85%
业务
地区
业务USD
名称
营收
占比
Oncology
150.56M
74.00%
Biopharma and data
45.38M
22.30%
Screening
5.68M
2.79%
Licensing and other
1.86M
0.91%
股东统计
更新时间: 6月21日 周六
更新时间: 6月21日 周六
持股股东
股东类型
持股股东
持股股东
占比
The Vanguard Group, Inc.
9.73%
BlackRock Institutional Trust Company, N.A.
6.95%
Deep Track Capital LP
4.39%
Capital International Investors
4.16%
Baillie Gifford & Co.
4.09%
Other
70.69%
持股股东
持股股东
占比
The Vanguard Group, Inc.
9.73%
BlackRock Institutional Trust Company, N.A.
6.95%
Deep Track Capital LP
4.39%
Capital International Investors
4.16%
Baillie Gifford & Co.
4.09%
Other
70.69%
股东类型
持股股东
占比
Investment Advisor
38.09%
Investment Advisor/Hedge Fund
33.25%
Hedge Fund
21.67%
Individual Investor
4.57%
Research Firm
2.22%
Bank and Trust
1.82%
Sovereign Wealth Fund
1.81%
Pension Fund
1.28%
Insurance Company
0.03%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
741
129.90M
104.85%
-16.16M
2025Q1
783
130.34M
105.23%
-16.59M
2024Q4
746
130.16M
105.47%
-20.09M
2024Q3
780
137.29M
111.53%
-9.70M
2024Q2
801
127.50M
103.74%
-18.45M
2024Q1
826
124.00M
101.88%
-12.71M
2023Q4
856
120.18M
99.30%
-14.26M
2023Q3
867
117.78M
100.31%
-19.15M
2023Q2
890
119.83M
102.55%
+840.96K
2023Q1
908
101.46M
98.78%
-16.37M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
12.05M
9.73%
+28.83K
+0.24%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
8.61M
6.95%
-284.70K
-3.20%
Mar 31, 2025
Deep Track Capital LP
5.44M
4.39%
-975.85K
-15.20%
Mar 31, 2025
Capital International Investors
5.15M
4.16%
+674.48K
+15.08%
Mar 31, 2025
Baillie Gifford & Co.
5.06M
4.09%
-388.09K
-7.12%
Mar 31, 2025
Cadian Capital Management LP
4.60M
3.71%
-626.48K
-12.00%
Mar 31, 2025
Two Sigma Investments, LP
4.19M
3.38%
-12.65K
-0.30%
Mar 31, 2025
Citadel Advisors LLC
3.60M
2.9%
+2.12M
+142.72%
Mar 31, 2025
Eventide Asset Management, LLC
3.57M
2.88%
-241.20K
-6.33%
Mar 31, 2025
Capital Research Global Investors
2.93M
2.37%
+190.45K
+6.95%
Mar 31, 2025
查看更多
持股ETF
更新时间: 7月6日 周日
更新时间: 7月6日 周日
机构名称
占比
ARK Genomic Revolution ETF
6.11%
Global X Genomics & Biotechnology ETF
3.8%
Invesco Dorsey Wright Healthcare Momentum ETF
3.24%
Franklin Genomic Advancements ETF
2.43%
First Trust Nasdaq Lux Digi Health Solutions ETF
2.21%
ROBO Global Healthcare Technology & Innovation ETF
2.12%
Alger Mid Cap 40 ETF
1.85%
SPDR S&P Health Care Services ETF
1.82%
BNY Mellon Innovators ETF
1.39%
iShares Health Innovation Active ETF
1.23%
查看更多
ARK Genomic Revolution ETF
占比6.11%
Global X Genomics & Biotechnology ETF
占比3.8%
Invesco Dorsey Wright Healthcare Momentum ETF
占比3.24%
Franklin Genomic Advancements ETF
占比2.43%
First Trust Nasdaq Lux Digi Health Solutions ETF
占比2.21%
ROBO Global Healthcare Technology & Innovation ETF
占比2.12%
Alger Mid Cap 40 ETF
占比1.85%
SPDR S&P Health Care Services ETF
占比1.82%
BNY Mellon Innovators ETF
占比1.39%
iShares Health Innovation Active ETF
占比1.23%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
